论文部分内容阅读
尿激酶（ＵＫ）为第一代溶栓药。近年来在心脑血管疾病的治疗中，取得了明显的疗效。现将我院用大剂量ＵＫ一次性冲击治疗脑血栓形成急性期患者４０例的疗效观察报告如下。资料与方法一、一般资料治疗组４０例，男２６例，女１４例，年龄３４～６８岁，平均５６．５岁。另设对
Urokinase (UK) is the first generation of thrombolytic drugs. In recent years in the treatment of cardiovascular and cerebrovascular diseases, and achieved significant results. Now our hospital with a large dose of UK one-time impact treatment of acute cerebral thrombosis in 40 patients reported the following reports. Materials and Methods First, the general information The treatment group 40 cases, 26 males and 14 females, aged 34 to 68 years, mean 56.5 years. Another set of right